The Latest Breaking News from Pfizer

The Covid vaccine programme has been extended further to include children aged five to 11 without underlying health conditions, in a bid to protect against potential future waves of Covid-19

Macy's Inc (NYSE: M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

As the omicron wave peaked in the U.S. last month, the first-line treatment for high-risk patients with early COVID-19 dangled out of reach for most. Only a trickle of the new Paxlovid pill from Pfizer Inc. was reaching hospitals and pharmacies.

Biotech stocks are down and out right now. But sentiment can turn on a dime. Here are trends to watch in the biotech sector in 2022.

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 25 strange trades.

Pfizer/BioNTech jab to be offered to younger children as experts decide benefits outweigh risks

This blog is now closed.

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

Most parents want their children aged 5-11 to be vaccinated and prefer they receive the Pfizer vaccine produced using mRNA technology, a survey has revealed.

Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.